Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion
Marco Lucioni, Francesca Novara, Giacomo Fiandrino, et al.
Blood (2011) Vol. 118, Iss. 17, pp. 4591-4594
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
Maria Rosaria Sapienza, Francesco Abate, Federica Melle, et al.
Haematologica (2018) Vol. 104, Iss. 4, pp. 729-737
Open Access | Times Cited: 69
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Kamel Laribi, Alix Baugier de Materre, Mohamad Sobh, et al.
Blood Advances (2020) Vol. 4, Iss. 19, pp. 4838-4848
Open Access | Times Cited: 58
Sex-BiasedZRSR2Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
Katsuhiro Togami, Sun Sook Chung, Vikas Madan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 522-541
Open Access | Times Cited: 46
Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis
Florian Renosi, Anne Roggy, Ambre Giguelay, et al.
Blood Advances (2021) Vol. 5, Iss. 5, pp. 1540-1551
Open Access | Times Cited: 45
Plasmacytoid dendritic cell neoplasms
Yoo Jin Lee, Youjin Kim, Sang Hyuk Park, et al.
Blood Research (2023) Vol. 58, Iss. S1, pp. S90-S95
Open Access | Times Cited: 19
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies
Kamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Biology of Blood and Marrow Transplantation (2016) Vol. 22, Iss. 8, pp. 1357-1367
Open Access | Times Cited: 57
Blastic Plasmacytoid Dendritic Cell Neoplasm
Joseph D. Khoury
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 477-483
Closed Access | Times Cited: 53
Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review
Marie JeongMin Kim, Ahmed Nasr, Bilaal Kabir, et al.
Journal of Pediatric Hematology/Oncology (2017) Vol. 39, Iss. 7, pp. 528-537
Closed Access | Times Cited: 53
Blastic Plasmacytoid Dendritic Cell Neoplasm–Current Insights
Sangeetha Venugopal, Selena Zhou, Siraj M. El Jamal, et al.
Clinical Lymphoma Myeloma & Leukemia (2019) Vol. 19, Iss. 9, pp. 545-554
Closed Access | Times Cited: 47
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patients
Naveen Pemmaraju, Branko Cuglievan, Joseph A. Lasky, et al.
eJHaem (2024) Vol. 5, Iss. 1, pp. 61-69
Open Access | Times Cited: 5
Cutaneous Lymphomas
Werner Kempf, Dmitry V. Kazakov, Katrin Kerl
American Journal of Dermatopathology (2014) Vol. 36, Iss. 2, pp. 105-123
Open Access | Times Cited: 50
Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow
Alexandar Tzankov, Konnie M. Hebeda, Markus Kremer, et al.
Annals of Hematology (2017) Vol. 96, Iss. 5, pp. 765-777
Closed Access | Times Cited: 41
Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant
Seongseok Yun, Onyee Chan, Daniel Kerr, et al.
Blood Advances (2020) Vol. 4, Iss. 14, pp. 3435-3442
Open Access | Times Cited: 39
Blastic plasmacytoid dendritic cell neoplasm: diagnosis, manifestations, and treatment
Kendra Sweet
Current Opinion in Hematology (2020) Vol. 27, Iss. 2, pp. 103-107
Closed Access | Times Cited: 37
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases
Raida Khwaja, Andrew Daly, Michael K. Wong, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2016) Vol. 57, Iss. 11, pp. 2720-2722
Closed Access | Times Cited: 38
8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms
Prajwal Boddu, Sa A. Wang, Naveen Pemmaraju, et al.
Leukemia Research (2018) Vol. 66, pp. 73-78
Closed Access | Times Cited: 36
Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events
Zhenya Tang, Yan Li, Wei Wang, et al.
Leukemia Research (2018) Vol. 73, pp. 86-94
Closed Access | Times Cited: 35
Diagnostic approach to blastic plasmacytoid dendritic cell neoplasm: historical perspectives and current understanding
Kana Sakamoto, Kengo Takeuchi
Journal of Clinical and Experimental Hematopathology (2025) Vol. 65, Iss. 1, pp. 1-16
Open Access
CLTC‐ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm
Kiriko Tokuda, Minenori Eguchi‐Ishimae, Chihiro Yagi, et al.
Genes Chromosomes and Cancer (2013) Vol. 53, Iss. 1, pp. 78-89
Closed Access | Times Cited: 34
An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality
Lhara Sumarriva Lezama, Karen M. Chisholm, Eugene Carneal, et al.
Histopathology (2018) Vol. 73, Iss. 5, pp. 767-776
Closed Access | Times Cited: 27
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review
Yazan Samhouri, Sorana G Ursu, Nina Dutton, et al.
Journal of Oncology Pharmacy Practice (2020) Vol. 27, Iss. 4, pp. 990-995
Closed Access | Times Cited: 22
Immunotherapies Targeting CD123 for Blastic Plasmacytoid Dendritic Cell Neoplasm
Tongyuan Xue, Lihua E. Budde
Hematology/Oncology Clinics of North America (2020) Vol. 34, Iss. 3, pp. 575-587
Closed Access | Times Cited: 21
Leukemic Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm Lacking Skin Lesion : A Borderline Case between Acute Monocytic Leukemia
Yoko Takiuchi, Hayato Maruoka, Kazunari Aoki, et al.
Journal of Clinical and Experimental Hematopathology (2012) Vol. 52, Iss. 2, pp. 107-111
Closed Access | Times Cited: 25

Scroll to top